HAEMATO AG (HAM:HAEK)

Germany flag Germany · Delayed Price · Currency is EUR
10.10
+0.10 (1.00%)
At close: Oct 2, 2025
1.00%
Market Cap54.89M
Revenue (ttm)260.81M
Net Income (ttm)9.61M
Shares Out5.23M
EPS (ttm)1.88
PE Ratio5.60
Forward PEn/a
Dividend0.04 (0.40%)
Ex-Dividend DateJul 16, 2025
Volume341
Average Volume329
Open9.50
Previous Close10.00
Day's Range9.50 - 10.10
52-Week Range9.40 - 15.40
Beta0.22
RSI48.32
Earnings Daten/a

About HAEMATO AG

HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. It operates through Specialty Pharma and Lifestyle & Aesthetics segments. The company engages in the development, acquisition, licensing, and distribution of prescription drugs and OTC products, special cosmetics, as well as dietary supplements. In addition, it provides pharmaceuticals in the areas of HIV/AIDS, neurology, oncology, and rheumatology diseases. Further, the company develops, manufactures, and distributes diagnostic tests under the HAEMATO... [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries
Founded 1993
Employees 61
Stock Exchange Hamburg Stock Exchange
Ticker Symbol HAEK
Full Company Profile

Financial Performance

In 2022, HAEMATO AG's revenue was 248.14 million, a decrease of -12.95% compared to the previous year's 285.04 million. Earnings were 8.19 million, an increase of 25.39%.

Financial Statements

News

There is no news available yet.